Cargando…
Expression of p16(INK) (4a) is a biomarker of chondrocyte aging but does not cause osteoarthritis
Cellular senescence drives a functional decline of numerous tissues with aging by limiting regenerative proliferation and/or by producing pro‐inflammatory molecules known as the senescence‐associated secretory phenotype (SASP). The senescence biomarker p16 (INK) (4a) is a potent inhibitor of the cel...
Autores principales: | Diekman, Brian O., Sessions, Garrett A., Collins, John A., Knecht, Anne K., Strum, Susan L., Mitin, Natalia K., Carlson, Cathy S., Loeser, Richard F., Sharpless, Norman E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6052464/ https://www.ncbi.nlm.nih.gov/pubmed/29744983 http://dx.doi.org/10.1111/acel.12771 |
Ejemplares similares
-
Comet assay for quantification of the increased DNA damage burden in primary human chondrocytes with aging and osteoarthritis
por: Copp, Michaela E., et al.
Publicado: (2022) -
Cells exhibiting strong p16(INK4a) promoter activation in vivo display features of senescence
por: Liu, Jie-Yu, et al.
Publicado: (2019) -
Chemotherapy and Stem Cell Transplantation Increase p16(INK4a) Expression, a Biomarker of T-cell Aging
por: Wood, William A., et al.
Publicado: (2016) -
Does walking during chemotherapy impact p16(INK4a)
levels in women with early breast cancer
por: Kammire, Maria S., et al.
Publicado: (2022) -
Somatic p16(INK4a) loss accelerates melanomagenesis
por: Monahan, K B, et al.
Publicado: (2010)